MeMAGEN: A Phase IIa/IIb open‐label trial of memantine testing safety and tolerability in sickle cell patients
- DOI
- 10.1002/hem3.70278
- Published
- 2026-01
- Container
- HemaSphere
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/hem3.70278,
title = {MeMAGEN: A Phase IIa/IIb open‐label trial of memantine testing safety and tolerability in sickle cell patients},
author = {Ariel Koren and Carina Levin and Leonid Livshits and Fabio Valeri and Sari Peretz and Sivan Raz and Anna Yu Bogdanova and Max Gassmann},
year = {2026},
journal = {HemaSphere},
doi = {10.1002/hem3.70278},
url = {https://doi.org/10.1002/hem3.70278}
}RIS
TY - JOUR TI - MeMAGEN: A Phase IIa/IIb open‐label trial of memantine testing safety and tolerability in sickle cell patients AU - Ariel Koren AU - Carina Levin AU - Leonid Livshits AU - Fabio Valeri AU - Sari Peretz AU - Sivan Raz AU - Anna Yu Bogdanova AU - Max Gassmann PY - 2026 JO - HemaSphere DO - 10.1002/hem3.70278 UR - https://doi.org/10.1002/hem3.70278 ER -
APA
Koren, A., Levin, C., Livshits, L., Valeri, F., Peretz, S., Raz, S., Bogdanova, A. Y., & Gassmann, M. (2026). MeMAGEN: A Phase IIa/IIb open‐label trial of memantine testing safety and tolerability in sickle cell patients. HemaSphere. https://doi.org/10.1002/hem3.70278
Source records
- crossref · retrieved 2026-09-27T11:41:25.412Z